Signature biomarkers in Diabetes Mellitus and associated Cardiovascular diseases

Clinical Hemorheology and Microcirculation

Volumn 59, Issue 1, 2015, Pages 67-81

  Karmakar, Tanusri ^a   Mallick, Sanjaya K ^b   Chakraborty, Arpita ^a   Maiti, Animesh ^c   Chowdhury, Subhankar ^d   Bhattacharyya, Maitree ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b BD CU Center of Excellence for Nanobiotechnology   (India)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

^d INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

flow cytometry; mitochondrial membrane potential; Platelets; ROS; surface markers; vWF

Indexed keywords

BIOLOGICAL MARKER; DUAL SPECIFICITY PHOSPHATASE 2; FIBRINOGEN RECEPTOR; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; MAJOR CLINICAL STUDY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE POTENTIAL; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; THROMBOCYTE; THROMBOCYTE MEMBRANE; THROMBOCYTE STRUCTURE; WESTERN BLOTTING; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

BIOMARKERS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; P-SELECTIN; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REACTIVE OXYGEN SPECIES; RISK FACTORS; VON WILLEBRAND FACTOR;

EID: 84923272422     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-141818     Document Type: Article

References (39)

1. S. Adak, S. Chowdhury and M. Bhattacharyya, Dynamic and electrokinetic behavior of erythrocyte membrane in diabetes mellitus and diabetic cardiovascular disease, Biochimica Et Biophysica Acta 1780 (2008), 108-115.
2. A.J. Begonja, S. Gambaryan, J. Geiger, B. Aktas, M. Pozgajova, B. Nieswandt and U.Walter, Platelet NAD(P)H-oxidasegenerated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway, Blood 106 (2005), 2757-2760.
3. A.D. Blann, S.K. Nadar and G.Y. Lip, The adhesion molecule P-selectin and cardiovascular disease, European Heart Journal 24 (2003), 2166-2179.
4. R. Budhiraja, R.M. Tuder and P.M. Hassoun, Endothelial dysfunction in pulmonary hypertension, Circulation 109 (2004), 159-165.
5. M.E. Carr, Diabetes mellitus: A hypercoagulable state, Journal of Diabetes and Its Complications 15 (2001), 44-54.
6. A. Celi, G. Pellegrini, R. Lorenzet, A. De Blasi, N. Ready, B.C. Furie and B. Furie, P-selectin induces the expression of tissue factor on monocytes, Proceedings of the National Academy of Sciences of the United States of America 91 (1994), 8767-8771.
7. A. Chakraborty, S. Chowdhury and M. Bhattacharyya, Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients, Diabetes Research and Clinical Practice 93 (2011), 56-62.
8. A. Chakraborty, T. Karmakar, S. Chowdhury and M. Bhattacharyya, Effect of Metformin on pathological indices related to cardiovascular disease in diabetes, AJBBL 1 (2012), 53-64.
9. J.L. Ferreiro, J.A. Gomez-Hospital and D.J. Angiolillo, Platelet abnormalities in diabetes mellitus, Diabetes & Vascular Disease Research 7 (2010), 251-259.
10. F. Giacco and M. Brownlee, Oxidative stress and diabetic complications, Circulation Research 107 (2010), 1058-1070.
11. P. Gresele, G. Guglielmini, M. De Angelis, S. Ciferri, M. Ciofetta, E. Falcinelli, C. Lalli, G. Ciabattoni, G. Davi and G.B. Bolli, Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus, Journal of the American College of Cardiology 41 (2003), 1013-1020.
12. S.M. Grundy, Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome, The American Journal of Cardiology 81 (1998), 18B-25B.
13. P. Gyawali, R.S. Richards, D.L. Hughes and P. Tinley, Clinical Hemorheology and Microcirculation (2013). DOI 10.3233/CH-131792
14. B. Hechler,Y. Zhang, A. Eckly,, et al., Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice, Journal of Thrombosis and Haemostasis 1(1) (2003), 155-163.
15. H. Holmsen, Biochemistry of the platelet: Energy metabolism, Philadelphia, Lippincott 1987.
16. R. Kaplan, J. Gabbeta, L. Sun, G.F. Mao and A.K. Rao, Combined defect in membrane expression and activation of platelet GPIIb-IIIa complex without primary sequence abnormalities in myeloproliferative disease, British Journal of Haematology 111 (2000), 954-964.
17. H. King, R.E. Aubert and W.H. Herman, Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections, Diabetes Care 21 (1998), 1414-1431.
18. V. Kumar, N. Fausto, A.K. Abbas, R.S. Cotran and S.L. Robbins, Robbins and Cotran Pathologic Basis of Disease, Philadelphia, Pa.: Saunders 7th ed. (2005), 1194-1195.
19. T. Kunicki, D.J. Nugent, S.J. Staats, R.P. Orchekowski, E.A. Wayner and W.G. Carter, The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and is identical to the platelet glycoprotein Ia-IIa complex, Journal of Biological Chemistry 263 (1988), 4516.
20. V. Leytin and J. Freedman, Platelet apoptosis in stored platelet concentrates and other models, Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 28 (2003), 285-295.
21. G.Y. Lip and A. Blann, vonWillebrand factor: A marker of endothelial dysfunction in vascular disorders? Cardiovascular Research 34 (1997), 255-265.
22. J.J. Lopez, G.M. Salido, E. Gomez-Arteta, J.A. Rosado and J.A. Pariente, Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets, Journal of Thrombosis and Haemostasis: JTH 5 (2007), 1283-1291.
23. A.H. Mokdad, B.A. Bowman, E.S. Ford, F. Vinicor, J.S. Marks and J.P. Koplan, The continuing epidemics of obesity and diabetes in the United States, JAMA: The Journal of the American Medical Association 286 (2001), 1195-1200.
24. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, T.J. Orchard, P. Raskin and B. Zinman, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, The New England Journal of Medicine 353 (2005), 2643-2653.
25. G. Nickenig, Should angiotensin II receptor blockers and statins be combined? Circulation 110 (2004), 1013-1020.
26. H.K. Niewenhuis, J.W.N. Akkerman, W.P.M. Houdijk and J.J. Sixma, Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia, Nature 318 (1985), 470.
27. E. Pongrácz, K. Schweitzer, J. Fürész, J. JFent, A. Tordai and Z. Nagy, The effects of platelet receptor GPIIb/IIIa polymorphism (Leu Pro33) on the receptor expression and platelet aggregation in patients with ischaemic stroke, Turk J Hematol 24 (2007), 155-163.
28. M.K. Reddy,A. Banerjee,W.A. Banks and N. Ercal, Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells, Free Radical Biology & Medicine 50 (2011), 801-810.
29. W.H. Reinhart, Platelets in vascular disease, Clinical Hemorheology and Microcirculation 53 (2013), 71-79.
30. A. Saha, S. Adak, S. Chowdhury and M. Bhattacharyya, Enhanced oxygen releasing capacity and oxidative stress in diabetes mellitus and diabetes mellitus-associated cardiovascular disease: A comparative study, Clinica Chimica Acta; International Journal of Clinical Chemistry 361 (2005), 141-149.
31. S.A. Santoro, Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen, Cell 46 (1986), 913.
32. D.J. Schneider, Factors contributing to increased platelet reactivity in people with diabetes, Diabetes Care 32 (2009), 525-527.
33. J.W. Semple, K.A. Siminovitch, M. Mody,Y. Milev, A.H. Lazarus, J.F. Wright and J. Freedman, Flowcytometric analysis of platelets from children with theWiskott-Aldrich syndrome reveals defects in platelet development, activation and structure, British Journal of Haematology 97 (1997), 747-754.
34. R.C. Shuster, A.J. Rubenstein and D.C. Wallace, Mitochondrial DNA in anucleate human blood cells, Biochemical and Biophysical Research Communications 155 (1988), 1360-1365.
35. R.S. Sohal and B.H. Sohal, Hydrogen peroxide release by mitochondria increases during aging, Mechanisms of Ageing and Development 57 (1991), 187-202.
36. D. Tschoepe, P. Roesen, J. Esser, B. Schwippert, H.K. Nieuwenhuis, B. Kehrel and F.A. Gries, Large platelets circulate in an activated state in diabetes mellitus, Seminars in Thrombosis and Hemostasis 17 (1991), 433-438.
37. A.I. Vinik, T. Erbas, T.S. Park, R. Nolan and G.L. Pittenger, Platelet dysfunction in type 2 diabetes, Diabetes Care 24 (2001), 1476-1485.
38. C.Watala and A.B. Sobol, The role of platelets in diabetes-related vascular complications, Diabetes Research and Clinical Practise 50 (2000), 1-16.
39. P. Zimmet, K.G. Alberti and J. Shaw, Global and societal implications of the diabetes epidemic, Nature 414 (2001), 782-787.